Conditions: semaglutide · 2 mg/mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the…
content-assay
Page 15 of 19 · 438 questions tagged content-assay.
The method section is present, which is unusual enough that I want to make use of it. Please show the division. I want to check my own against yours. I would like the…
This is my second independent submission on material from the same supplier. I would rather understand the derivation than memorise the outcome. Two people I asked…
The case in front of me: 96.4% · liraglutide · WXT. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I…
Setup, so nobody has to ask: dimerisation · cagrilintide · 40 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…
The particulars: 98.4% · ecnoglutide · SGN. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
Setup, so nobody has to ask: ERP · cagrilintide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Details up front: WWB · orforglipron. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
What I am working with: aggregation · mazdutide · 2–8 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I would like the arithmetic checked rather than the conclusion asserted. I…
The particulars: 97.6% · survodutide · SWB. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…
Details up front: a sterility test · orforglipron. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
This is my second independent submission on material from the same supplier. I understand the observation; what I do not understand is the mechanism behind it. I have…
The particulars: 97.9% · ecnoglutide · WWB. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
What I have: a GLP-1 receptor agonist · 10 mg/mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I…
Conditions: 95.2% · tirzepatide · ERP. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write down,…
The particulars: deamidation · semaglutide · minus 20 °C. I understand the observation; what I do not understand is the mechanism behind it. I have read the two…
The method section is present, which is unusual enough that I want to make use of it. I have read the primary source rather than the summary, which has left me with…
Details up front: 98.2% · orforglipron · MKM. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
Concretely: Homopeptide · liraglutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several times…
Setup, so nobody has to ask: 96.4% · cagrilintide · Homopeptide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but…
Conditions: TFC · tirzepatide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
Stated plainly: ERP · a GLP-1 receptor agonist. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I want the working, not the result — I need to be able to redo it with…